Internal Medicine, Nephrology · New York, NY
NPI
1154588572
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
424 E 70th St
New York, NY, 10021
Phone (646) 962-2606
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
959 services
Medicare patients, 2024
155
Average age 63
Drug cost, 2024
$709K
2,272 prescriptions
Company payments, 2024
$1,362
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John R Lee was code 99232 (hospital e&m - subsequent), 276 times for 57 patients. In total John R Lee billed 959 services in 10 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 276 | 57 | $72.13 | $20K |
| 99214 Office E&M - Established | Facility | 266 | 79 | $79.44 | $21K |
| 99213 Office E&M - Established | Office | 203 | 65 | $75.13 | $15K |
| 99213 Office E&M - Established | Facility | 117 | 66 | $48.38 | $5,660 |
| 99233 Hospital E&M - Subsequent | Facility | 43 | 31 | $108.98 | $4,686 |
| 99214 Office E&M - Established | Office | 32 | 22 | $101.30 | $3,241 |
By year: 2022 $86K for 951 services; 2023 $111K for 1,463 services; 2024 $72K for 959 services.
Medicare prescription drug claims, 2024
In 2024, the drug John R Lee prescribed most often to Medicare patients was Nifedipine Er (Nifedipine), with 170 prescriptions and refills. In total John R Lee wrote 2,272 Medicare prescriptions that cost $709K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nifedipine Er Nifedipine | 170 | 353 | 44 | $4,164 |
| Atovaquone Generic | 137 | 150 | 32 | $57K |
| Amlodipine Besylate Generic | 129 | 305 | 42 | $1,113 |
| Prednisone Generic | 95 | 169 | 25 | $589 |
| Tamsulosin Hcl Generic | 93 | 198 | 22 | $960 |
| Valganciclovir Hcl Generic | 83 | 161 | 33 | $27K |
| Carvedilol Generic | 75 | 188 | 22 | $444 |
| Atorvastatin Calcium Generic | 69 | 179 | 22 | $777 |
| Lokelma Sodium Zirconium Cyclosilicate | 66 | 78 | 22 | $58K |
| Cinacalcet Hcl Generic | 61 | 151 | 20 | $40K |
| Clonidine Hcl Generic | 59 | 97 | 14 | $271 |
| Bumetanide Generic | 57 | 94 | 14 | $1,395 |
| Pantoprazole Sodium Generic | 56 | 134 | 19 | $625 |
| Tacrolimus Generic | 51 | 103 | Under 11 | $7,125 |
| Famotidine Generic | 51 | 107 | 20 | $481 |
Brand drugs: 267 claims; generic drugs: 1,991 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid John R Lee $1,362 ($1,362 in general payments such as food, travel and fees) from 2 companies. The largest payer was Calliditas Therapeutics US Inc. with $1,236.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $1,236 |
| Genzyme Corporation SNY | 1 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.